Related Articles
Prevalence of the Janus kinase 2 V617F mutation in Philadelphia‑negative myeloproliferative neoplasms in a Portuguese population
Determination of prognosis of Philadelphia chromosome‑negative myeloproliferative neoplasms with a simple clinical examination: Retrospective analysis of 71 patients in a single institution
Co‑existence of triple‑negative essential thrombocythemia and double transcript chronic myeloid leukemia: A case report
Clinical significance of circulating microparticles in Ph- myeloproliferative neoplasms
pSTAT5 and ERK exhibit different expression in myeloproliferative neoplasms